EUCTR2006-006815-62-GB进行中（未招募）1 期
Does N-Acetylcysteine (Parvolex) prophylaxis reduce the incidence of renal impairment after on pump Coronary artery bypass surgery? A prospective randomised controlled trial.
niversity Hospitals of South Manchester NHS Foundation Trust0 个研究点目标入组 224 人开始时间: 2007年4月17日最近更新:
适应症
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 224
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Patients undergoing elective coronary artery bypasssurgery at Wythenshawe Hospital Manchester
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
排除标准
- •Urgent and emergency cases
- •Patients with history of hypersensitivity to N-Acetylcysteine
- •Patients already taking N-Acetylcysteine
- •Patients with existing renal failure (creatinine more than 120mmol/l –upper limit of normal range in our laboratory
研究者
相似试验
已完成
不适用
Does N-Acetylcysteine (Parvolex®) prophylaxis reduce the incidence of renal impairment after onpump Coronary Artery Bypass Graft surgery? A prospective randomised controlled trialRenal impairmentUrological and Genital DiseasesRenal diseasesISRCTN71629284niversity Hospital of South Manchester NHS Foundation Trust (UK)224
已完成
不适用
Does prophylactic N-AcetylCysteine decrease incidence of contrast nephropathy in patients undergoing peripheral angiography?Contrast induced nephropathyUrological and Genital DiseasesNephropathyISRCTN35882618Cambridge University Hospital NHS Trust (UK)40
已完成
不适用
Does prophylactic N acetylcysteine decrease the incidence of contrast nephropathy in patients undergoing endovascular abdominal aortic aneurysm (AAA) repair?Surgery: Abdominal aortic aneurysm (AAA) repairSurgeryAbdominal aortic aneurysm (AAA) repairISRCTN69248640Record Provided by the NHSTCT Register - 2004 Update - Department of Health (UK)20
进行中（未招募）
1 期
Does prophylactic N acetylcysteine reduce the incidence of contrast nephropathy in patients undergoing peripheral angiography - NAC as a Nehroprotective agent in Peripheral AngiographyEUCTR2005-005809-38-GBResearch & Development Department, Addenbrookes Hospital40
已完成
不适用
Effect of N - Acetylcysteine in the prevention of ototoxicity caused by vancomycin.Peritonitis.Peritonitis, unspecifiedIRCT201202148032N2Research Assistance Of Tabriz University Of Medical Science60